The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Dadofthree,
Look at clinical trial sheet, it states "not yet recruited patients, updated on 27th April, so you're at least a week premature.
https://clinicaltrials.gov/ct2/show/NCT04363372?term=MRx-4DP0004&cond=Covid-19&draw=2&rank=1
Notmy job,
Think the trial start will have to be RNS'd, as it's an important milestone.
Hopefully, as some say, Monday.
Could be anytime soon.
Not yet
https://clinicaltrials.gov/ct2/show/NCT04363372?term=MRx-4DP0004&cond=Covid-19&draw=2&rank=1
Status: not yet recruiting,
Start date : May 2020,
Est Prim completion: Aug 2020,
Est Study completion: Sep 2020
Miss Marbles, Contract started on 4th May.
oops "stuck" is "stick"
They all have specific business plans and stuck to the rules, this could include:
% profit, % of company, time held vs profit etc.
Each company is specific.
He's gone too far. Unstable, needs sectioning.
Ghia,
On top of that have you noticed that all trades around 10,000 or more are showing up an hour late on LSE trades.
This is confusing as they are showing up as unknown, so in my opinion they are trying to confuse the PI's and accommodate the seller.
All dodgy imo, plus these other trades reported a day late.
"can't tell my ar. se from my elbow" what's going on.
Good luck all tomorrow.
Not nearly 5m, but now at 9.34m
Should see 2 good trading days and hopefully clear the background seller.
This should then release the shackles ready for next good news.
Looking great imo
Thanks Trek, great explanation. Confidence restored.
If you re calculate graph from daily to weekly, it shows the massive potential here.
Especially when you link it in to the presentation and see potential products. WOW
I posted this comment yesterday at 18.55 but nobody picked up on it, so thought it wasn't important.
""From this doc, this bit is very positive "Hospitalised patients in SG016 who have subsequently been discharged home during the 14-day treatment period, have been successfully taking the study medication at home. "
Notice the word "successfully".""
Candid,
"What’s more it’s not only for Covid-19 but any respiratory viral infection that may develop in the future."
Agree, as this gives longevity to the product.
From this doc, this bit is very positive "Hospitalised patients in SG016 who have subsequently been discharged home during the 14-day treatment period, have been successfully taking the study medication at home. "
Notice the word "successfully".
Oilornothing,
Just been trying to find where it was said on twitter, but it seems to have gone. On this basis I retract comment until I can find it again. Sorry if I'm wrong,
He did state it was a stage 2 trial going to stage 3.
Tocilzumab is already a used drug so don't think it could be this.
Got to be SNG imo
Scarabeatle,
Yes Landsdown have been selling down since the placing (last 3 holding RNS's have been them)
From the excellent posts in the last few weeks, I have no doubt that we are in for a biggy in the near future, if not tomorrow.
Thanks to all the experts on here
This is by far the best board on LSE for rational discussions, but beware on next move up, all the "nutters" will arrive.
Hold firm and ignore them ( includes all boomers and trolls)
Thnx, still very positive either way :)
Maqsood,
This bit is interesting "Positive initial results from the 100 patient pilot phase could see the trial expanded to more hospitals, with Synairgen increasing production of the drug in parallel.".
Does this mean the first 100 on the trial were all at Southampton, cos if it does, we know trial has expanded to other hospitals.
This means that the results MUST HAVE been positive.